The diabetic foot.

Diabetic foot problems are responsible for nearly 50% of all diabetes-related hospital bed days. Approximately 10-15% of diabetic patients developed foot ulcers at some state in their life and 15% of all load in amputations are performed in patients with diabetes. There is a need to provide extensive education to both primary care physicians and the patients regarding the relationship between glucose control and complications encountered in the foot and ankle. The management of diabetic foot disease is focussed primarily on avoiding amputation of lower extremities and should be carried out through three main strategies; identification of the "at risk" foot, treatment of acutely diseased foot, and prevention of further problems. These are several obstacles in the management of DFI that include poor knowledge and awareness of diabetes and its complications, lack of appropriate podiatry services. These goals are possible only by the establishment of a dedicated team of podiatrist, endocrinologist, vascular surgeon and a pedorthist. The plastic surgeons, orthopaedic surgeons & diabetes teaching nurses/educator dedicated to foot care could be a part of the team. Identifying the patients with diabetes at risk for ulceration requires feet examination, including the vascular & neurological systems, skin conditions, and foot structure. Conservative management of foot problems has dramatically reduced the risk of amputation by simple procedures, such as appropriate foot wear, cleanliness, aggressive surgical debridement, regular wound dressing by simple wet-to-dry saline guage, and ulcer management.

[1]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[2]  A. Jirkovska,et al.  Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy , 2006, Diabetes Care.

[3]  A. Manto,et al.  Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. , 2005, Diabetes care.

[4]  Kirk E. Smith,et al.  Structural Changes in the Forefoot of Individuals with Diabetes and a Prior Plantar Ulcer , 2002, The Journal of bone and joint surgery. American volume.

[5]  Benjamin A Lipsky,et al.  The value of a wound score for diabetic foot infections in predicting treatment outcome: A prospective analysis from the SIDESTEP trial , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[6]  B. De,et al.  Complications of Diabetes Mellitus , 2016 .

[7]  W. Marston,et al.  Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. , 2006, Journal of vascular surgery.

[8]  J. R. Mekkes,et al.  Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation , 1999, Archives of Dermatological Research.

[9]  A. M. Foster,et al.  Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial , 2001, Diabetologia.

[10]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[11]  D. Armstrong,et al.  Preventing foot ulcers in patients with diabetes. , 2005, JAMA.

[12]  F. Logerfo,et al.  Lower extremity revascularization in diabetes: late observations. , 2000, Archives of surgery.

[13]  A. Malik,et al.  Study of plasmid-mediated extended-spectrum β-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital. , 2012, Diabetes technology & therapeutics.

[14]  K. Brismar,et al.  Skin Capillary Circulation is More Impaired in the Toes of Diabetic Than Non‐diabetic Patients with Peripheral Vascular Disease , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[15]  D G Smith,et al.  The Independent Contributions of Diabetic Neuropathy and Yasculopatny in Foot Ulceration: How great are the risks? , 1995, Diabetes Care.

[16]  C. Cetrulo,et al.  Endostatin Inhibits Ischemia-Induced Neovascularization and Increases Ischemic Tissue Loss , 2004, Annals of plastic surgery.

[17]  J. Varani,et al.  All-trans-retinoic acid suppresses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture. , 2004, The American journal of pathology.

[18]  J. Chung,et al.  Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. , 2000, The Journal of investigative dermatology.

[19]  N. Schaper,et al.  Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies , 2004, Diabetes/Metabolism Research Reviews.

[20]  A C Shore,et al.  Skin Capillary Density in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[21]  C. Sumner,et al.  The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.

[22]  P. Mandal,et al.  A comparative study between total contact casting and conventional dressings in the non-surgical management of diabetic plantar foot ulcers. , 2008, Journal of the Indian Medical Association.

[23]  A. Malik,et al.  A study of biofilm production by gram-negative organisms isolated from diabetic foot ulcer patients , 2011 .

[24]  I. Baumgartner,et al.  Balloon Angioplasty in Chronic Critical Limb Ischemia: Factors Affecting Clinical and Angiographic Outcome , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[25]  P. Sönksen,et al.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.

[26]  P. Stewart,et al.  Biofilms in chronic wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[27]  R J Hinchliffe,et al.  Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment , 2008, Diabetes/metabolism research and reviews.

[28]  T. H. Lee,et al.  Charcot foot: the diagnostic dilemma. , 2001, American family physician.

[29]  T. Dinh,et al.  Microvascular Changes in the Diabetic Foot , 2006, The international journal of lower extremity wounds.

[30]  Jamal Ahmad,et al.  Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. , 2011, Foot.